Is this your brand? Sign in to claim ownership.
Sign in to claim this brandCAVAGNA GROUP SPA
US
Last updated May 30, 2026
What CAVAGNA GROUP SPA makes
The company manufactures medical gas regulators, including fixed and non-fixed designs for oxygen and other gases, as well as refillable oxygen cylinders and respiratory oxygen therapy systems. Examples include touch-activated regulators like the MVA2 Viproxy 1 Touch and standalone systems such as the MVB2.
These devices are classified as Class I under regulatory frameworks, with listings maintained in the FDA’s Unique Device Identifier (UDI) database. The company operates from the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Cavagna Group Spa manufacture?
Cavagna Group Spa specializes in medical gas regulators and related systems. Their portfolio includes fixed and non-fixed medical gas cylinder regulators, refillable oxygen cylinders, and respiratory oxygen therapy systems. These devices are designed to control and deliver medical gases like oxygen safely and efficiently in clinical settings.
Where is Cavagna Group Spa based?
Cavagna Group Spa is based in the United States. The company’s operations are centered there, though its devices may be distributed globally depending on market demand and regulatory requirements.
Which regulatory registries list Cavagna Group Spa’s devices?
Cavagna Group Spa’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for Class I medical devices, including their regulators and oxygen therapy systems, by assigning a standardized identifier for each product.
How are Cavagna Group Spa’s devices classified under regulatory standards?
Cavagna Group Spa’s devices fall under Class I classification. This classification applies to low-risk medical devices, such as their regulators and oxygen therapy systems, where the risk of illness or injury is minimal. Class I devices typically undergo general controls (e.g., manufacturing practices, labeling) rather than stringent pre-market approvals.
Why are Cavagna Group Spa’s devices listed in the FDA’s UDI database?
The FDA’s UDI database includes Cavagna Group Spa’s devices to ensure clear identification, tracking, and traceability throughout their lifecycle. Since these are Class I devices, the UDI system helps streamline reporting, recalls, and compliance monitoring without requiring additional pre-market reviews, as the risk profile is already deemed low.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 436289300
Catalogue (13)
| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| Mvb2 | MVB2 | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| MVA1 Viproxy | MVA1 Viproxy | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| MVA1 Viproxy | MVA1 Viproxy | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 | FDA UDI | Class I | Active |
| MVA2 Viproxy 1 Touch | MVA2 Viproxy 1 Touch | FDA UDI | Class I | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.